Bicycle Therapeutics Announces Leadership Changes for Oncology Pipeline Growth

Bicycle Therapeutics has announced leadership transitions, with Travis Thompson appointed as chief financial officer, Michael Method promoted to chief medical officer, and Michael Skynner transitioning to chief scientific officer. Alethia Young has stepped down as CFO and will remain with the company as an advisor, while Eric Westin has retired as CMO and will continue as a distinguished fellow. The changes position Bicycle for innovation across its oncology pipeline, with strengthened operational capacity and financial runway expected into 2028.